Quantcast

Latest Guillain-Barre syndrome Stories

2009-04-22 13:15:00

18 patient advocacy and health care professional groups join with Congressional sponsors Reps. Israel, Brady and Schwartz to announce new legislation; call for patient access to IVIG WASHINGTON, April 22 /PRNewswire-USNewswire/ -- Members of Congress and patient advocacy groups announced today the introduction of new legislation - H.R. 2002, Medicare Patient IVIG Access Act of 2009 - meant to remedy inadequate Medicare reimbursements that currently restrict patient access to Intravenous...

2009-04-22 09:00:30

Former Chicago Bears defensive back William The Refrigerator Perry is reported in serious condition at a hospital near his home in Aiken, S.C. Perry, 46, was diagnosed last June with Guillain-Barre syndrome, an inflammatory disorder of the peripheral nerves outside the brain and spinal cord, the Chicago Tribune reported Wednesday. At the time, Perry spent six months in the hospital because of complications related to the illness. His agent, Adam Plotkin, says Perry developed chronic...

2009-02-16 23:55:50

The human papillomavirus vaccine has not increased risks of Guillain-Barre but it warrants monitoring, U.S. researchers said. Thirty-six cases of Guillain-Barre syndrome -- a muscle disorder caused by the immune system attacking the peripheral nervous system -- have occurred after HPV vaccination. The vaccine has been in use since June 2006 after being approved by the U.S. government for use in girls ages 9-26 to protect against some types of HPV that can cause cervical cancer. Using data...

2008-10-07 09:00:55

NARBERTH, Pa., Oct. 7 /PRNewswire/ -- The GBS/CIDP Foundation International will host its tenth international symposium on Guillain-Barre Syndrome (GBS) and Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) in Bloomingdale, IL on November 7-9, 2008. Over 250 medical professionals, current and former patients and caregivers from all over the world are expected to attend the three-day event at the Indian Lake Resort. In addition to general sessions covering the latest developments in...

2008-09-23 12:00:13

A study of a treatment for chronic inflammatory demyelinating neuropathy (CIDP) suggests that 50 percent of the patients who responded to treatment with Gamunex (Immune Globulin Intravenous (Human), 10% Caprylate/Chromatography Purified) required two treatments before they first exhibited improvements on a standard disability measurement scale, according to data presented at the American Neurological Association meeting in Salt Lake City, Utah. The study authors concluded that "further...

2008-09-23 09:00:15

Sub-analysis from a Phase III study of patients with a neurological disease, chronic inflammatory demyelinating polyneuropathy (CIDP), suggest that therapy with Gamunex (Immune Globulin Intravenous (Human), 10% Caprylate/Chromatography Purified) may improve their physical and social functioning compared to placebo. Improvements in clinical symptoms also correlated with improvements in nerve function, according to the study funded by Talecris Biotherapeutics, Inc. The data were reported...

2008-09-15 09:00:11

Talecris Biotherapeutics, Inc. announced today the U.S. Food and Drug Administration (FDA) has granted approval for Gamunex (Immune Globulin Intravenous (Human), 10% Caprylate/Chromatography Purified) as a treatment for chronic inflammatory demyelinating polyneuropathy (CIDP). CIDP is a debilitating neurological disorder that results in muscle weakness and fatigue, which can lead to severe impairment of motor skills. Through its approval, Gamunex is the only therapy of any kind with an...

2006-08-17 19:41:32

NEW YORK (Reuters Health) - Two cases of melioidosis, an infectious disease caused by the bacterium Burkholderia pseudomallei that is rare in the US, were reported to the Florida Department of Health in 2005. Both patients had recently visited or arrived from Honduras, where the disease is endemic. One case resulted in paraplegia, and the other in death. In the CDC's Morbidity and Mortality Report for August 18, Dr. Aaron Kite-Powell, from the Broward County Health Department in...

2006-04-06 12:48:14

NEW YORK (Reuters Health) - Three more cases of Guillain-Barre syndrome (GBS), a neurological disorder involving temporary paralysis, have been reported in people given the Menactra vaccine to prevent meningitis. The additional cases bringing the total number reported to eight, according to an article in the Morbidity and Mortality Weekly Report, published by the Centers for Disease Control and Prevention. Still, when the eight cases of Menactra-related GBS were compared against the...

2005-09-30 19:14:15

By Lisa Richwine WASHINGTON (Reuters) - U.S. officials are investigating if a Sanofi-Aventis meningitis vaccine may have caused five cases of a rare neurological disorder that can paralyze its victims, the government announced on Friday. The patients -- all 17 or 18 years old -- developed Guillain-Barre Syndrome, or GBS, after receiving Sanofi's Menactra vaccine, which was approved for sale in January. All are recovering or have recovered, officials said. The cases under...


Word of the Day
humgruffin
  • A terrible or repulsive person.
Regarding the etymology of 'humgruffin,' the OED says (rather unhelpfully) that it's a 'made-up word.' We might guess that 'hum' comes from 'humbug' or possibly 'hum' meaning 'a disagreeable smell,' while 'gruffin' could be a combination of 'gruff' and 'griffin.'